137 related articles for article (PubMed ID: 29704625)
1. Tricyclic antidepressants inhibit hippocampal α7* and α9α10 nicotinic acetylcholine receptors by different mechanisms.
Arias HR; Vázquez-Gómez E; Hernández-Abrego A; Gallino S; Feuerbach D; Ortells MO; Elgoyhen AB; García-Colunga J
Int J Biochem Cell Biol; 2018 Jul; 100():1-10. PubMed ID: 29704625
[TBL] [Abstract][Full Text] [Related]
2. Selectivity of (±)-citalopram at nicotinic acetylcholine receptors and different inhibitory mechanisms between habenular α3β4* and α9α10 subtypes.
Arias HR; Jin XT; Gallino S; Peng C; Feuerbach D; García-Colunga J; Elgoyhen AB; Drenan RM; Ortells MO
Neurochem Int; 2019 Dec; 131():104552. PubMed ID: 31545995
[TBL] [Abstract][Full Text] [Related]
3. Different interaction between tricyclic antidepressants and mecamylamine with the human alpha3beta4 nicotinic acetylcholine receptor ion channel.
Arias HR; Targowska-Duda KM; Feuerbach D; Sullivan CJ; Maciejewski R; Jozwiak K
Neurochem Int; 2010 Mar; 56(4):642-9. PubMed ID: 20117161
[TBL] [Abstract][Full Text] [Related]
4. Bupropion-induced inhibition of α7 nicotinic acetylcholine receptors expressed in heterologous cells and neurons from dorsal raphe nucleus and hippocampus.
Vázquez-Gómez E; Arias HR; Feuerbach D; Miranda-Morales M; Mihailescu S; Targowska-Duda KM; Jozwiak K; García-Colunga J
Eur J Pharmacol; 2014 Oct; 740():103-11. PubMed ID: 25016090
[TBL] [Abstract][Full Text] [Related]
5. Tricyclic antidepressants and mecamylamine bind to different sites in the human alpha4beta2 nicotinic receptor ion channel.
Arias HR; Rosenberg A; Targowska-Duda KM; Feuerbach D; Jozwiak K; Moaddel R; Wainer IW
Int J Biochem Cell Biol; 2010 Jun; 42(6):1007-18. PubMed ID: 20223294
[TBL] [Abstract][Full Text] [Related]
6. Novel 2-(substituted benzyl)quinuclidines inhibit human α7 and α4β2 nicotinic receptors by different mechanisms.
Arias HR; López JJ; Feuerbach D; Fierro A; Ortells MO; Pérez EG
Int J Biochem Cell Biol; 2013 Nov; 45(11):2420-30. PubMed ID: 23954208
[TBL] [Abstract][Full Text] [Related]
7. Tricyclic antidepressants inhibit homomeric Cys-loop receptors by acting at different conformational states.
Gumilar F; Bouzat C
Eur J Pharmacol; 2008 Apr; 584(1):30-9. PubMed ID: 18314100
[TBL] [Abstract][Full Text] [Related]
8. Interaction of selective serotonin reuptake inhibitors with neuronal nicotinic acetylcholine receptors.
Arias HR; Feuerbach D; Targowska-Duda KM; Russell M; Jozwiak K
Biochemistry; 2010 Jul; 49(27):5734-42. PubMed ID: 20527991
[TBL] [Abstract][Full Text] [Related]
9. (-)-Reboxetine inhibits muscle nicotinic acetylcholine receptors by interacting with luminal and non-luminal sites.
Arias HR; Ortells MO; Feuerbach D
Neurochem Int; 2013 Nov; 63(5):423-31. PubMed ID: 23917086
[TBL] [Abstract][Full Text] [Related]
10. Tabernanthalog and ibogainalog inhibit the α7 and α9α10 nicotinic acetylcholine receptors via different mechanisms and with higher potency than the GABA
Tae HS; Ortells MO; Yousuf A; Xu SQ; Akk G; Adams DJ; Arias HR
Biochem Pharmacol; 2024 May; 223():116183. PubMed ID: 38580167
[TBL] [Abstract][Full Text] [Related]
11. DM506 (3-Methyl-1,2,3,4,5,6-hexahydroazepino[4,5-
Tae HS; Ortells MO; Tekarli BJ; Manetti D; Romanelli MN; McIntosh JM; Adams DJ; Arias HR
ACS Chem Neurosci; 2023 Jul; 14(14):2537-2547. PubMed ID: 37386821
[TBL] [Abstract][Full Text] [Related]
12. Different Classes of Antidepressants Inhibit the Rat α7 Nicotinic Acetylcholine Receptor by Interacting within the Ion Channel: A Functional and Structural Study.
Duarte Y; Rojas M; Canan J; Pérez EG; González-Nilo F; García-Colunga J
Molecules; 2021 Feb; 26(4):. PubMed ID: 33668529
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms of inhibition of nicotinic acetylcholine receptors by tricyclic antidepressants.
Gumilar F; Arias HR; Spitzmaul G; Bouzat C
Neuropharmacology; 2003 Dec; 45(7):964-76. PubMed ID: 14573389
[TBL] [Abstract][Full Text] [Related]
14. Drimane Sesquiterpenoids Noncompetitively Inhibit Human α4β2 Nicotinic Acetylcholine Receptors with Higher Potency Compared to Human α3β4 and α7 Subtypes.
Arias HR; Feuerbach D; Schmidt B; Heydenreich M; Paz C; Ortells MO
J Nat Prod; 2018 Apr; 81(4):811-817. PubMed ID: 29634269
[TBL] [Abstract][Full Text] [Related]
15. Selectivity of coronaridine congeners at nicotinic acetylcholine receptors and inhibitory activity on mouse medial habenula.
Arias HR; Jin X; Feuerbach D; Drenan RM
Int J Biochem Cell Biol; 2017 Nov; 92():202-209. PubMed ID: 29042244
[TBL] [Abstract][Full Text] [Related]
16. Bupropion and its photoreactive analog (±)-SADU-3-72 interact with luminal and non-luminal sites at human α4β2 nicotinic acetylcholine receptors.
Arias HR; Feuerbach D; Ortells MO
Neurochem Int; 2016 Nov; 100():67-77. PubMed ID: 27612850
[TBL] [Abstract][Full Text] [Related]
17. Novel positive allosteric modulators of the human α7 nicotinic acetylcholine receptor.
Arias HR; Gu RX; Feuerbach D; Guo BB; Ye Y; Wei DQ
Biochemistry; 2011 Jun; 50(23):5263-78. PubMed ID: 21510634
[TBL] [Abstract][Full Text] [Related]
18. Coronaridine congeners inhibit human α3β4 nicotinic acetylcholine receptors by interacting with luminal and non-luminal sites.
Arias HR; Targowska-Duda KM; Feuerbach D; Jozwiak K
Int J Biochem Cell Biol; 2015 Aug; 65():81-90. PubMed ID: 26022277
[TBL] [Abstract][Full Text] [Related]
19. Antagonism of nicotinic acetylcholine receptors by inhibitors of monoamine uptake.
López-Valdés HE; García-Colunga J
Mol Psychiatry; 2001 Sep; 6(5):511-9. PubMed ID: 11526465
[TBL] [Abstract][Full Text] [Related]
20. Positive allosteric modulators of α7 nicotinic acetylcholine receptors affect neither the function of other ligand- and voltage-gated ion channels and acetylcholinesterase, nor β-amyloid content.
Arias HR; Ravazzini F; Targowska-Duda KM; Kaczor AA; Feuerbach D; Boffi JC; Draczkowski P; Montag D; Brown BM; Elgoyhen AB; Jozwiak K; Puia G
Int J Biochem Cell Biol; 2016 Jul; 76():19-30. PubMed ID: 27129924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
